Complete Filing Data
Cellebrite DI Ltd. reported Stockholders Equity of $484.32 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Cellebrite DI Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Selling And Marketing Expense | $154.8M | $132.4M | $110.8M | $97.4M | $76.4M | $61.3M | $61.6M |
| Research And Development Expense | $113.9M | $98.4M | $84.4M | $80.6M | $65.5M | $54.4M | $46.6M |
| Operating Income Loss | $66.5M | $56.9M | $33.2M | $1.0M | $13.8M | $9.2M | -$1.5M |
| Operating Expenses | $334.0M | $281.7M | $238.6M | $218.9M | $189.9M | $147.8M | $137.6M |
| Nonoperating Income Expense | $24.2M | -$332.9M | -$108.8M | $119.7M | $68.5M | $2.2M | $2.9M |
| Net Income Loss | $78.3M | -$283.0M | -$81.1M | $120.8M | $71.4M | $5.8M | -$1.9M |
| Income Tax Expense Benefit | $12.4M | $7.0M | $5.5M | -$45.0K | $10.9M | $5.6M | $3.3M |
| Gross Profit | $400.5M | $338.6M | $271.9M | $219.9M | $203.7M | $157.0M | $136.0M |
| General And Administrative Expense | $65.3M | $50.9M | $43.4M | $40.9M | $47.9M | $32.1M | $29.4M |
| Cost Of Revenue | $75.2M | $62.6M | $53.2M | $50.7M | $42.6M | $37.9M | $35.8M |
| Comprehensive Income Net Of Tax | $78.5M | -$282.0M | -$80.4M | $119.8M | $71.4M | $6.3M | -$1.3M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $90.7M | -$276.0M | -$75.6M | $120.8M | $82.3M | $11.4M | $1.4M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $134.0K | $1.0M | $719.0K | -$1.0M | $51.0K | $517.0K | $595.0K |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$1.3M | $1.4M | -$1.0M | $414.0K | $995.0K | -$695.0K | -$25.0K |
| Deferred Income Tax Assets Net | $10.9M | $11.1M | $7.0M | $12.5M | $9.8M | $7.4M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $475.7M | $401.2M | $325.1M | $270.7M | $246.2M | $194.9M | $171.9M |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent | $152.0K | $66.0K | $171.0K | $130.0K | $129.0K | $165.0K | |
| Income Taxes Paid Net | -$549.0K | $7.7M | $10.0M | $9.1M | $8.2M | $2.9M | $3.0M |
| Deferred Income Taxes And Tax Credits | $75.0K | -$4.0M | $5.1M | -$2.4M | -$1.6M | -$2.8M | -$1.7M |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax | $4.6M | -$172.0K | -$48.0K | -$3.5M | $364.0K | $3.0M | |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax | $1.1M | -$487.0K | $1.3M | -$953.0K | -$944.0K | $1.2M | |
| Other Comprehensive Income Loss Available For Sale Securities Tax | $35.0K | $33.0K | $2.0K | $189.0K | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $484.3M | $336.0M | $34.2M | $73.9M | -$73.3M | $63.8M | $58.8M | $69.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $124.5M | $191.7M | $189.5M | $87.6M | $146.0M | $133.8M | $81.7M | $36.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$69.7M | $3.3M | $101.3M | -$56.7M | $12.9M | $51.5M | $44.9M | |
| Treasury Stock Value | $85.0K | $85.0K | $85.0K | $85.0K | $85.0K | $85.0K | ||
| Retained Earnings Accumulated Deficit | -$86.5M | -$164.9M | $118.1M | $199.2M | $78.4M | $28.3M | ||
| Prepaid Expense And Other Assets Current | $19.6M | $23.2M | $26.4M | $17.1M | $12.8M | $7.4M | ||
| Other Assets Noncurrent | $14.6M | $7.7M | $7.3M | $1.7M | $2.0M | $565.0K | ||
| Liabilities Noncurrent | $84.9M | $59.0M | $244.8M | $121.7M | $226.6M | $40.0M | ||
| Liabilities Current | $369.7M | $295.5M | $253.8M | $207.8M | $186.6M | $159.4M | ||
| Liabilities And Stockholders Equity | $938.9M | $690.6M | $532.9M | $403.3M | $339.8M | $364.4M | ||
| Liabilities | $454.5M | $354.5M | $498.7M | $329.4M | $413.1M | $199.4M | ||
| Inventory Net | $7.6M | $8.9M | $9.9M | $10.2M | $6.5M | $4.8M | ||
| Intangible Assets Net Excluding Goodwill | $81.5M | $11.3M | $10.6M | $11.3M | $11.2M | $6.6M | ||
| Goodwill | $119.6M | $28.7M | $26.8M | $26.8M | $26.8M | $9.5M | ||
| Assets Noncurrent | $363.0M | $123.0M | $110.8M | $107.4M | $66.6M | $40.1M | ||
| Assets Current | $575.9M | $567.6M | $422.1M | $295.9M | $273.2M | $324.3M | ||
| Assets | $938.9M | $690.6M | $532.9M | $403.3M | $339.8M | $364.4M | ||
| Allowance For Doubtful Accounts Receivable Current | $506.0K | $594.0K | $1.6M | $1.9M | $1.0M | $616.0K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $2.2M | $2.1M | $1.1M | $331.0K | $1.4M | $1.3M | ||
| Accounts Payable Trade Current | $16.8M | $11.1M | $8.3M | $4.6M | $9.5M | $4.7M | ||
| Property Plant And Equipment Net | $22.2M | $17.0M | $15.9M | $17.3M | $16.8M | $16.1M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $44.9M | $30.6M | $19.0M | $13.7M | $6.5M | $7.3M | $12.8M |
| Payments To Acquire Property Plant And Equipment | $13.2M | $8.6M | $5.2M | $6.9M | $5.1M | $6.2M | $6.2M |
| Net Cash Provided By Used In Operating Activities | $173.5M | $132.2M | $102.1M | $20.6M | $36.1M | $66.5M | $16.1M |
| Net Cash Provided By Used In Investing Activities | -$268.3M | -$149.5M | -$22.5M | -$91.2M | $45.2M | -$6.4M | -$46.7M |
| Net Cash Provided By Used In Financing Activities | $25.1M | $20.7M | $21.8M | $14.0M | -$68.4M | -$8.6M | $75.5M |
| Increase Decrease In Accounts Payable Trade | $4.9M | $2.8M | $3.7M | -$5.5M | $4.2M | -$1.4M | $974.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.5M | -$1.2M | $589.0K | -$1.6M | -$754.0K | $695.0K | -$67.0K |
| Increase Decrease In Inventories | -$1.6M | -$982.0K | -$243.0K | $3.7M | $1.8M | $693.0K | -$794.0K |
| Increase Decrease In Other Noncurrent Assets | $6.9M | $341.0K | $5.6M | -$227.0K | $1.4M | $339.0K | $27.0K |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $4.2M | $17.6M | $734.0K | -$8.9M | $5.1M | $22.4M | -$158.0K |
| Depreciation Depletion And Amortization | $11.9M | $10.6M | $10.0M | $9.2M | $7.0M | $5.9M | $4.1M |
| Payments To Acquire Short Term Investments | $187.0M | $207.0M | $89.0M | $76.0M | $21.0M | $138.5M | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$5.6M | -$3.2M | $9.2M | $5.7M | $8.3M | -$335.0K | $3.1M |
| Increase Decrease In Other Noncurrent Liabilities | -$2.0M | $880.0K | $121.0K | -$4.1M | $3.0M | $1.4M | $644.0K |
| Proceeds From Stock Options Exercised | $20.1M | $17.3M | $19.1M | $12.6M | $2.3M | $1.5M | $141.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $153.0M | $60.0M | $56.3M | $22.3M | $0.00 | $0.00 | |
| Payments To Acquire Marketable Securities | $321.2M | $127.8M | $55.3M | $89.4M | $0.00 | $0.00 | |
| Payments To Acquire Intangible Assets | $0.00 | $2.0M | $2.7M | $2.2M | $3.0M | $0.00 | $0.00 |
| Increase Decrease In Contract With Customer Liability | $49.8M | $22.3M | $46.1M | $39.0M | $21.8M | $47.7M | $15.8M |
| Proceeds From Sale Of Short Term Investments | $187.9M | $138.7M | $73.4M | $60.9M | $94.3M | $153.3M | |
| Increase Decrease In Accounts Receivable | $15.8M | $5.8M | -$2.3M | $12.9M | $2.0M | $19.7M | $12.2M |
| Proceeds From Warrant Exercises | $0.00 | $53.0K | $0.00 | $5.0K | $0.00 | $0.00 | |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 5.0M | 3.3M | 2.6M | 1.3M | 0.00 | 0.00 | |
| Increase Decrease In Operating Lease Liability | $547.0K | -$4.8M | -$4.2M | -$6.0M | $0.00 | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 249.9M | 209.5M | 190.2M | 195.4M | 161.5M | 123.7M | 121.6M |
| Earnings Per Share Diluted | $0.31 | $-1.35 | $-0.43 | $0.59 | $0.44 | $-0.08 | $-0.08 |
| Earnings Per Share Basic | $0.32 | $-1.35 | $-0.43 | $0.64 | $0.49 | $-0.08 | $-0.08 |
| Weighted Average Number Of Shares Outstanding Basic | 241.6M | 209.5M | 190.2M | 182.7M | 144.0M | 123.7M | 121.6M |
| Common Stock Shares Outstanding | 248.6M | 234.5M | 203.2M | 193.0M | 187.7M | 124.7M | |
| Common Stock Shares Issued | 248.6M | 234.6M | 203.3M | 193.0M | 193.0M | 187.7M | |
| Common Stock Shares Authorized | 3.45B | 3.45B | 3.45B | 3.45B | 3.45B | 3.45B |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | $0.00 | $110.7M | $34.1M | -$36.5M | -$12.0M | $0.00 | $0.00 |
| Capitalized Contract Cost Net Current | $6.6M | $5.8M | $5.6M | $6.3M | $4.8M | $3.0M | |
| Additional Paid In Capital | $568.7M | $498.9M | -$84.9M | -$125.6M | -$153.1M | $34.2M | |
| Stock Issued During Period Value Stock Options Exercised | $24.9M | $20.5M | $21.7M | $13.7M | $2.3M | $1.5M | |
| Investment Income Net Amortization Of Discount And Premium | $2.4M | $2.9M | $1.1M | $372.0K | $0.00 | $0.00 | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $44.9M | $30.6M | $19.0M | $13.7M | $6.5M | $7.3M | $12.8M |
Most recent annual filing with the SEC: March 3, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.